presentation out today, page-5

Deca/Red GBI's sales and profitability certainly looks attractive but have a few quick questions to help me better understand all of this

What multiple is the Hologic deal being done at and you use 15x for GBI, why 15x?

Also in the last page they say that "$900k is included for non Paptype clinical development costs". Why do they include this in the expenses on page 19 but no revenues and if they include this why don't they include US clinical trial costs for Paptype?

cheers